|This Slide: #80 of 100|
Slide #80. Mesa Laboratories, Inc. — Amilabo SAS
Mesa Laboratories, Inc. (NASDAQ:MLAB)
Mesa Laboratories, Inc. (Nasdaq:MLAB) (we, us, our, "Mesa" or the "Company") today announced the acquisition of Amilabo SAS ("Amilabo"), a distributor of the Company's biological indicator (BI) products, located near Lyon, France. In this transaction, Mesa acquired all of the outstanding shares of Amilabo.
Mesa Laboratories designs, manufactures, and markets quality control products and services. Co.'s divisions include: Sterilization and Disinfection Control, which provides testing services, along with the manufacture and marketing of biological, chemical and cleaning indicators; Instruments, which designs, manufactures and markets quality control instruments and disposable products; Biopharmaceutical Development, which develops, manufactures, and commercializes automated solutions for protein analysis (immunoassays) and peptide synthesis; and Continuous Monitoring, which designs, develops and markets systems which are used to monitor various environmental parameters.
MLAB SEC Filing Email Alerts Service
Open the MLAB Page at The Online Investor »
Strong Buy (4.00 out of 4)
(ranked higher than approx. 88% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite